Healthequity Inc Dossier
|
SectorHealth Care IndustryHealth Information Services Beta (adjusted)0.49 Intrinsic Value $180.38median of 6 methods · middle span $77-$283based on filings through 31 Jul 2026 Market Price $89.37Price as of 1 Oct 2026 Significantly undervaluedIntrinsic value is 102% above the market price −50% · IV below pricenear fair value ±15%IV above price · +50% marker beyond scale (+102%) Data confidence Sign in to view data confidence Market Cap $7.4B Enterprise Value $8.1B Shares Outstanding 83.9M diluted Moat Rating Wide All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary HealthEquity, Inc. (NASDAQ: HQY) is the nation's largest independent health savings account (HSA) custodian, uniquely positioned to benefit from structural shifts in healthcare affordability that place more financial responsibility on consumers. The company's business model exhibits strong compounding characteristics driven by steady account growth, expanding custodial assets, and increasing operating leverage. Recent financial results demonstrate robust execution, highlighted by record gross margins and significant Adjusted EBITDA margin expansion to 46% in Q1 Fiscal 2027. With a massive addressable market expansion supported by recent regulatory tailwinds (such as direct primary care and pre-deductible telehealth eligibility) and a highly disciplined capital allocation strategy—including a newly expanded $1.0 billion share buyback program—HealthEquity represents a high-quality growth platform trading at an attractive valuation relative to its long-term earnings power. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$105.00 Mean target$118.53 High · most bullish analyst$135.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $88.0015% A severe downturn in the U.S. labor market that curtails new employer-sponsored account openings, combined with a rapid decline in interest rates that compresses custodial cash yields. Additionally, aggressive fee competition from integrated payers or zero-fee financial giants could pressure margins and slow asset accumulation. Base CaseCentral scenario $118.5360% Matches the consensus meanSteady organic account growth of 7-9% annually, stable custodial yields supported by the company's rate lock and forward hedging programs, and disciplined execution of the expanded share repurchase program. Operating margins continue to benefit from technology-enabled cost controls, supporting steady double-digit earnings growth. Bull CaseUpside scenario $135.0025% Accelerated HSA adoption driven by regulatory expansions, faster-than-expected migration of custodial cash to enhanced rate contracts, and rapid realization of AI-driven operational efficiencies. This scenario projects significant margin expansion and market share gains, driving the stock toward the high end of Wall Street estimates. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
Thesis Invalidation Triggers
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |